Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Gross Profit: 2019-2024

Historic Gross Profit for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $557.9 million.

  • Harmony Biosciences Holdings' Gross Profit rose 25.51% to $179.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $641.7 million, marking a year-over-year increase of 19.66%. This contributed to the annual value of $557.9 million for FY2024, which is 21.08% up from last year.
  • As of FY2024, Harmony Biosciences Holdings' Gross Profit stood at $557.9 million, which was up 21.08% from $460.8 million recorded in FY2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Gross Profit peaked at $557.9 million during FY2024, and registered a low of $132.0 million during FY2020.
  • Moreover, its 3-year median value for Gross Profit was $460.8 million (2023), whereas its average is $457.7 million.
  • Data for Harmony Biosciences Holdings' Gross Profit shows a peak YoY soared of 2,887.87% (in 2020) over the last 5 years.
  • Harmony Biosciences Holdings' Gross Profit (Yearly) stood at $132.0 million in 2020, then skyrocketed by 89.33% to $249.9 million in 2021, then skyrocketed by 41.79% to $354.4 million in 2022, then surged by 30.03% to $460.8 million in 2023, then rose by 21.08% to $557.9 million in 2024.